Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
US10493080B2 · kind B2 · utility
1Cited by
3References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 27, 2017 |
| Grant date | Dec 3, 2019 |
| Priority date | — |
| Expiry date | Jan 27, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of inducing differentiation of oligodendrocyte progenitor cells to a mature myelinating cell fate with a neurotransmitter receptor modulating agent. The present invention also provides methods of stimulating increased myelination in a subject in need thereof by administering said neurotransmitter receptor modulating agent. Methods of treating a subject having a demyelinating disease using a neurotransmitter receptor modulating agent are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.